Stock Movers: Boeing Upgrade and Moderna's New COVID Vaccine Approval

Boeing Stock Performance

• ✈️ Boeing (BA) shares saw a significant gain, initially rising much higher before market sell-offs, driven by an upgrade from Bank of America.
• 📈 Bank of America upgraded Boeing to 'buy' with the highest target price on the street at $260, citing its aircraft as a favored trade tool for the Trump administration.
• 🤝 The upgrade was supported by analyst mentions of deals with Qatar Airways and China ending its ban on Boeing aircraft deliveries.
• 📊 Fundamental reasons for the stock boost include progress in stabilizing production, with the stock up 20% year-to-date.
• 📦 The key driver for cash flow is the delivery of the 737, with hopes for continued production ramp-up.

Moderna's Vaccine Approval and Stock Movement

• 💉 Moderna (MRNA) shares experienced a jump, initially up 5% and settling around 2%, following FDA approval for its second-generation COVID vaccine.
• 🧑‍⚕️ The approval covers adults over 65 and individuals over 16 with at least one risk factor for severe disease.
• ⚠️ Analysts from William Blair view the approval as an incremental win, not a massive boost to sales, and note potential obstacles for vaccine makers under the current administration.
• 📈 Despite some analyst caution, the positive development offers a glimmer of hope for vaccine makers, though the stock has seen volatility with jumps and retracements.